Keyphrases
Treatment Response
100%
Significant Markers
100%
Pediatric Malignancy
100%
Restaging
100%
Serum Vascular Endothelial Growth Factor
100%
VEGF Levels
71%
Working Diagnosis
57%
One-child
42%
Tumor Progression
42%
Response to Treatment
28%
Progressive Disease
28%
Clinical Trials
14%
Remission
14%
Serum Levels
14%
Malignancy
14%
Commercially Available
14%
Cancer Types
14%
Immunoassay
14%
Large Group
14%
Complete Remission
14%
Prognostic Information
14%
Pediatric Patients
14%
Hodgkin Disease
14%
Local Recurrence
14%
First-line Therapy
14%
Hepatoblastoma
14%
Alpha-fetoprotein
14%
Patient with Tumor
14%
Very Good Partial Response
14%
Antiangiogenic Therapy
14%
Induction Therapy
14%
Ewing Sarcoma
14%
First-line Chemotherapy
14%
Reinduction Therapy
14%
Nursing and Health Professions
Treatment Response
100%
Childhood Cancer
100%
Vasculotropin
100%
Malignant Neoplasm
20%
Tumor Growth
20%
Remission
13%
Diseases
13%
Pilot Study
6%
Blood Level
6%
Recurrent Disease
6%
Pediatrics Patient
6%
Enzyme Linked Immunosorbent Assay
6%
Hodgkin Disease
6%
Immunoassay
6%
Fetoprotein
6%
Ewing Sarcoma
6%
Antiangiogenic Therapy
6%
Hepatoblastoma
6%
Medicine and Dentistry
Treatment Response
100%
Childhood Cancer
100%
Vasculotropin
100%
Malignant Neoplasm
20%
Tumor Progression
20%
Progressive Disease
13%
Clinical Trial
6%
Cancer
6%
Recurrent Disease
6%
Enzyme Linked Immunosorbent Assay
6%
Immunoassay
6%
Hodgkin's Lymphoma
6%
Pediatrics Patient
6%
Fetoprotein
6%
Ewing Sarcoma
6%
Antiangiogenic Therapy
6%
Hepatoblastoma
6%
First-Line Chemotherapy
6%
Pharmacology, Toxicology and Pharmaceutical Science
Childhood Cancer
100%
Vasculotropin
100%
Malignant Neoplasm
20%
Tumor Growth
20%
Remission
13%
Diseases
13%
Clinical Trial
6%
Recurrent Disease
6%
Enzyme-Linked Immunosorbent Assay
6%
Hodgkin Disease
6%
Immunoassay
6%
Antiangiogenic Therapy
6%
Ewing Sarcoma
6%
Hepatoblastoma
6%
Fetoprotein
6%
First-Line Chemotherapy
6%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
Tumor Progression
20%
Blood Level
6%
Immunoassay
6%
Clinical Trial
6%
Ewing Sarcoma
6%